Credit Suisse Ag Curis Inc Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $31,001 - $106,103	-43,664 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $5,825 - $12,937	2,522 Added 6.13%	43,664 $105,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $8,900 - $16,180	2,000 Added 5.11%	41,142 $196,000
Q3 2021 Nov 12, 2021	SELL	$6.94 - $8.85 $157,704 - $201,107	-22,724 Reduced 36.73%	39,142 $307,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $320,975 - $700,976	43,084 Added 229.39%	61,866 $498,000
Q1 2021 May 14, 2021	BUY	$8.78 - $12.8 $164,905 - $240,409	18,782 New	18,782 $213,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $495M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.